Problems › Should We Enter a New Market? › Banks & Financial Services
Market attractiveness is the easy half. Right to win is the half that decides the outcome. This page works through it for banks and financial services firms specifically — including an unedited excerpt from a real analysis of a bank.
Market attractiveness is the easy half. Right to win is the half that decides the outcome. For banks and financial services firms, this shows up in a particular place. The numbers that carry the answer are efficiency ratio and cost of funds, and the complication specific to this industry is that the branch network is simultaneously the deposit moat and the cost problem — and the relationship knowledge sits in six people close to retirement. The general version of this problem and the one you are actually in have different first moves.
New markets get evaluated on size and growth, both of which are knowable and neither of which predicts success. The predictive question is what you already have that transfers — a customer relationship, a distribution route, a cost position, a body of data — and what has to be built from nothing.
A market can be highly attractive and a bad idea for you specifically. The reverse is also true: a dull market where you have a structural advantage will usually outperform an exciting one where you start level with everyone.
The other discipline is a stated kill criterion before entry, because market entries are unusually good at consuming budget quietly for years on the argument that they are nearly there.
These three together are the signature. One on its own usually points somewhere else.
✓ The case rests mainly on market size and growth rate
✓ Nobody has written down what would make you stop
✓ The existing business is flat and the new market is being asked to fix it
The move that usually makes it worse. Entering because the core business has stalled, which takes management attention away from the problem that actually needs it.
It is for you if you run or finance a bank and the case rests mainly on market size and growth rate. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on a bank. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Harborline Financial Group, a sample company profile used for testing rather than a customer — $3.1B commercial lending book, $410M of deposits.
Excerpt from a real Percision run · Competitive Positioning · sample company profile
The move. Turn 11 cost centers holding $410M cheap deposits into fee-generating treasury/wealth hubs without new branches or external capital.
| Investment required | $4–6M total over 18 months, fully funded from $25–30M three-year retained-earnings capacity; no external capital required. |
| Expected return | Incremental $2.5–4M annual treasury fees by Year 3 on $148M base revenue; 42–67% incremental fee-income lift on the 18% baseline. |
| Revenue, year 1 | $148M–$149M |
| Revenue, year 2 | $150M–$152M |
| Revenue, year 3 | $152M–$158M |
| Exit criteria | Strategy should be reversed if, within 18 months, (a) treasury fee income run-rate has not reached $500K annualized from pilot branches, OR (b) commercial loan-to-deposit overlap has fallen below 60% for two consecutive quarters, OR (c) any single loss-making branch shows contribution margin. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Market Entry & Expansion Strategy, one of 29 engagements the platform runs. For banks and financial services firms it works through efficiency ratio, cost of funds, origination per banker and deposit concentration, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
List what you already own that the new market values, and what a credible incumbent there owns that you do not. If the second list is longer and includes anything structural — distribution, regulation, data depth — entry is a build, not an extension.
Set the number before you start, and treat exceeding it as the kill criterion rather than as a reason to invest more. Most failed entries were never killed, only slowly starved.
Whichever reuses more of what you already have. Geography usually reuses the product and rebuilds distribution; a new segment usually reuses distribution and rebuilds the product. Whichever rebuild is smaller is the safer bet.
Materially, yes. The branch network is simultaneously the deposit moat and the cost problem — and the relationship knowledge sits in six people close to retirement — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are efficiency ratio, cost of funds, origination per banker, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on efficiency ratio and cost of funds. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.